-

Pentagon investing millions in battlefield rapid disease detection
The handheld device will reportedly be able to test blood or fluid samples on future battlefields without needing refrigeration or temperature control.
-

Back to war: Wounded Ukrainians return to battle after amputation
Many brigades have at least one amputee soldier still on active duty — men who returned to combat despite the grim outlook for their country.
-

Army Stinger missile replacement competition heads into flight tests
Lockheed Martin and RTX are competing to develop the U.S. Army’s replacement for its Stinger short-range air defense missile it no longer produces.
-
Pentagon investing millions in battlefield rapid disease detection
The handheld device will reportedly be able to test blood or fluid samples on future battlefields without needing refrigeration or temperature control.
-
Back to war: Wounded Ukrainians return to battle after amputation
Many brigades have at least one amputee soldier still on active duty — men who returned to combat despite the grim outlook for their country.
-
Army Stinger missile replacement competition heads into flight tests
Lockheed Martin and RTX are competing to develop the U.S. Army’s replacement for its Stinger short-range air defense missile it no longer produces.
-
Pentagon investing millions in battlefield rapid disease detection
The handheld device will reportedly be able to test blood or fluid samples on future battlefields without needing refrigeration or temperature control.
-
Back to war: Wounded Ukrainians return to battle after amputation
Many brigades have at least one amputee soldier still on active duty — men who returned to combat despite the grim outlook for their country.
-
Army Stinger missile replacement competition heads into flight tests
Lockheed Martin and RTX are competing to develop the U.S. Army’s replacement for its Stinger short-range air defense missile it no longer produces.










